Skip to main content
Ascletis Pharma Inc. logo

Ascletis Pharma Inc. — Investor Relations & Filings

Ticker · 1672 ISIN · KYG0520K1094 LEI · 254900SKEFCO9I3GPL05 HKEX Manufacturing
Filings indexed 1,479 across all filing types
Latest filing 2014-11-03 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1672

About Ascletis Pharma Inc.

http://www.ascletis.com

Ascletis Pharma Inc. is a fully integrated, R&D driven biotechnology company dedicated to the development and commercialization of potential best-in-class and first-in-class therapeutics. The company covers the entire value chain from discovery to sales. Ascletis primarily focuses on metabolic diseases, including chronic weight management, utilizing proprietary platforms such as Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD), Ultra-Long-Acting Platform (ULAP), and Peptide Oral Transport ENhancement Technology (POTENT). Key pipeline candidates include ASC30 (oral/subcutaneous GLP-1R agonist), ASC35 (GLP-1R/GIPR dual agonist), ASC36 (amylin receptor agonist), and ASC37 (GLP-1R/GIPR/GCGR triple agonist). The company also maintains active programs in viral diseases, NASH/PBC, and oncology.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2014
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/10/2014, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content is focused on changes in the company's share capital structure during a specific month. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting share capital movements, typical for compliance with exchange rules. It is not an announcement of a report, nor a full financial report or management commentary. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous compliance filings that do not fit other categories.
2014-11-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2014
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/9/2014, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a regulatory compliance report rather than a financial report or announcement of voting results. The document is lengthy (13,780 characters) and contains detailed data on share capital changes. Therefore, it fits best under the category of Regulatory Filings (RNS), as it is a general regulatory announcement about share capital movements that does not fit more specific categories like Share Issue/Capital Change (SHA) or Transaction in Own Shares (POS), since it covers a broad range of share capital movements and is a monthly return report to the exchange.
2014-10-03 English
INTERIM REPORT 2014
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report 2014' and contains detailed financial statements including condensed consolidated statements of profit or loss, financial position, changes in equity, cash flows, and notes to the financial statements. It covers the six months ended 30 June 2014, which is a period shorter than a full fiscal year. The presence of unaudited financial data, segment information, and management discussion and analysis further supports that this is a comprehensive interim financial report. The document length is substantial (15,000 characters), and it contains actual financial data rather than just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2014
2014-09-18 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2014
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/8/2014, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content is focused on changes in share capital and securities movements rather than financial performance, management commentary, or earnings. It is a regulatory filing reporting share capital movements for a specific month. The document is lengthy (13,782 characters) and contains detailed data, not just an announcement or certification. This type of document fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes.
2014-09-01 English
ANNOUNCEMENT OF INTERIM RESULTS 2014
Interim / Quarterly Report Classification · 100% confidence The document is titled 'ANNOUNCEMENT OF INTERIM RESULTS 2014' and contains detailed unaudited consolidated financial statements for the six months ended 30 June 2014, including profit or loss, financial position, segment information, notes to the condensed consolidated financial statements, and management discussion and analysis. The presence of actual financial data and analysis for a half-year period indicates this is a comprehensive interim financial report. The document is about 15,000 characters long, which is consistent with a full interim report rather than a brief announcement or summary. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2014
2014-08-25 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 95% confidence The document is a short announcement from the board of directors of World Houseware (Holdings) Limited stating the date of a board meeting where the interim results for the six months ended 30 June 2014 will be approved and possibly an interim dividend considered. It does not contain the interim financial report itself, only an announcement of the upcoming board meeting and the intention to release the interim results. The document length is only 1682 characters, which is quite short and consistent with an announcement rather than a full report. According to the rules, announcements about the timing or release of reports are classified as Report Publication Announcements (RPA), not as the interim report (IR) itself. Therefore, the correct classification is RPA with high confidence.
2014-08-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.